US researchers’ simulation results… “You have to get the vaccine quickly to save the most lives”
German media “providing implications while Astra vaccine is neglected in Germany”
viewer
A new coronavirus infection (Corona 19) vaccine with low efficacy has been shown to reduce the number of victims such as corona 19 confirmed, severely ill, and death by quickly inoculating a large number of people.
It is pointed out that if the vaccine is not given because of its low efficacy, or if it is given slowly, it will cost a person’s life.
In a paper published in the American Journal of Preventive Medicine (AJPM) by Bruce Y. Lee, a professor at the Graduate School of Public Health and Health Policy at the City University of New York, the results of simulations according to two scenarios are compared, according to Frankfurt, Germany. Delivered work (local time).
In the first scenario, one million Americans are vaccinated daily with Bioentech Pfizer or Modena vaccine, which has an average immune effect of more than 90%. It takes more than six months for 60% of the population to become immune.
In the second scenario, 1.5 million Americans are vaccinated daily with the Johnson & Johnson (J&J) vaccine, which has an average immune effect of about 66%. It takes only 4 months for 60% of the population to become immune.
If even a low-efficacy vaccine is given to more people quickly, as in the second scenario, the number of corona19 confirmed cases in the U.S. decreased by 1.38 million, hospital admissions decreased by 51,000, and deaths decreased by 6,000, the researchers explained.
Prof. Lee said, “Vaccination to many people as soon as possible saves the most lives. For individuals, getting a vaccine that is less effective is a fundamental protection measure that prevents COVID-19 from becoming severe.” .
FAZ pointed out that these findings provide implications for the fact that the AstraZeneca (AZ) vaccine, which has a low average immunity effect of 70.4%, has not been vaccinated and neglected in Germany. As a priority, only 16.5% of the AZ vaccines supplied to Germany have been vaccinated, as vaccination targets are reluctant to be vaccinated.
The governors of Bavaria, Baden-Wurttemberg, and Saxony of Germany insisted that all applicants should be vaccinated without applying the existing priorities regarding the AZ vaccine.
Regarding this, the relevant authorities say that the vaccination rate and priority are not related, and that the priority should be observed.
“In principle, it is true that vaccination should be done as soon as possible, but it is not related to vaccination speed and priority,” said Thomas Mertens, the German permanent vaccination committee. Because there is,” he pointed out.
Germany ranks first among senior citizens aged 80 years or older, residents of nursing homes or nursing homes, and medical staff who are at high risk of exposure to Corona 19, such as emergency rooms. As a priority, vaccinations are given to the elderly aged 70-75, those with underlying diseases, and those who have a lot of contact with pregnant women.
In the midst of this, Reuters reported on the 1st that France has expanded the scope of the AstraZeneca vaccine to be vaccinated so that even those 65 years of age or older with complications can be met.
French Health Minister Olivier Berand said on a local news channel BFMTV, “Anyone 50 years old or older with a complication can get the AstraZeneca vaccine.”
However, Citizens over the age of 75 can only be vaccinated with Pfizer-Bioentech, Modena, and Vaccines, Berang added.
Previously, France stipulated that AstraZeneca vaccine can be vaccinated under the age of 65. This is because the clinical trial data for this vaccine in the elderly are limited.
At the end of January, French President Emmanuel Macron made a statement stating that the AstraZeneca vaccine was not effective for people over 65 years old, and then scammed a backlash from Britain, the first in the world to approve the emergency use of the vaccine.
However, data on the efficacy of the vaccine have since been accumulated, including an announcement by a Scottish researcher that the AstraZeneca vaccine has a very high preventive effect.
In addition, it is interpreted that the authorities have eased the existing position due to the lack of vaccine supply from Pfizer-Bioentech and Modena in France.
On the other hand, other recommendations have been made in Canada, which has approved the use of the AstraZeneca vaccine in subjects over 18 years of age.
On that day, Canada’s National Immunity Advisory Committee recommended that people over 65 should not get the AstraZeneca vaccine, as data on the efficacy of the vaccine were too limited.
However, the Committee also added that the’substantial evidence’ that can be confirmed in the country where the vaccine is actually vaccinated is potentially beneficial and there are no safety issues.
/ Reporter Kihyuk Kim [email protected]
< 저작권자 ⓒ 서울경제, 무단 전재 및 재배포 금지 >